Phase I dose escalation clinical trial of phenylbutyrate sodium administered twice daily to patients with advanced solid tumors.
Invest New Drugs
; 25(2): 131-8, 2007 Apr.
Article
em En
| MEDLINE
| ID: mdl-17053987
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Fenilbutiratos
/
Neoplasias
/
Antineoplásicos
Limite:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Ano de publicação:
2007